GC Genome Corporation (KOSDAQ: A340450)
Health Care · Biotechnology · KR
₩9,870.00
+11.15% today · +39.8% 1Y
GC Genome Corporation (KOSDAQ: A340450) operates in the Biotechnology industry within the Health Care sector. The company is valued at $173.64M.
Over the last twelve months the share price has gained 39.8%, trading between 4.10K and 10.38K.
Tweenvest scores GC Genome Corporation across four factors: quality 71/100, value 40/100, growth 75/100. Its strongest factor is growth.
A340450 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $173.64M
- Revenue (TTM)
- $21.08M
- P/E
- 42.95
- EPS
- 229.79
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- ₩10,380.00
- 52-week low
- ₩4,100.00
- Avg volume (3M)
- —
- Shares outstanding
- 23.65M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Compass Therapeutics, Inc.NasdaqCM: CMPX | $178.83M | $0.94 | -5.59% |
| Cue Biopharma, Inc.NasdaqCM: CUE | $178.78M | $24.61 | -11.03% |
| Uwell Biopharma, Inc.TPEX: 7902 | $175.67M | NT$28.00 | -4.92% |
| ALX Oncology Holdings Inc.NasdaqGS: ALXO | $174.23M | $1.26 | +0.80% |
| TYK Medicines, IncSEHK: 2410 | $173.28M | HK$3.54 | -17.79% |
| PepGen Inc.NasdaqGS: PEPG | $172.46M | $2.49 | -4.96% |
| Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.SEHK: 2566 | $172.36M | HK$5.64 | -2.51% |
| ImmuneOnco Biopharmaceuticals (Shanghai) Inc.SEHK: 1541 | $171.05M | HK$3.13 | -7.54% |
Figures last refreshed Oct 11, 2026.